Sun Pharmaceutical Industries
BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
News on Sun Pharmaceutical Industries
Buy Sun Pharma, says Sudarshan Sukhani
3.20 pm | 17 Jun 2013 | Source: CNBC-TV18
With knee jerk reaction in Sun Pharma over and with an uptrend one can buy Sun Pharma, says Sudarshan Sukhani of s2analytics.com....
Bank Nifty can fall 4-5% more: Anand Rathi
7.58 pm | 14 Jun 2013 | Source: CNBC-TV18
There could be correction in Bank Nifty and PSU banks are definitely going to have difficult couple of quarters ahead of them, says Sandeep Shenoy, An...
Sun Pharma looks strong, says SP Tulsian
7.08 pm | 13 Jun 2013 | Source: CNBC-TV18
SP Tulsian of sptulsian.com says the bias on Sun Pharma is very strong. "One should take a long view on the stock," he adds....
Exit Sun Pharma, advises Parag Doctor
6.24 pm | 13 Jun 2013 | Source: CNBC-TV18
Parag Doctor, Head - Trading Strategies at Keynote Capital's advises to exit Sun Pharmaceutical. The stock may fall to Rs 900 in immediate term, Docto...
Sun Pharma slumps on $550m settlement with Pfizer
5.20 pm | 13 Jun 2013 | Source: Moneycontrol.com
Sun Pharma will pay USD 550 million to Pfizer to settle a case related to Protonix. This is higher than the USD 107 million it had set aside earlier. ...
Check out Tulsian's bets in IT & pharma space
5.07 pm | 10 Jun 2013 | Source: CNBC-TV18
SP Tulsian of sptulsian.com advised good ideas in the IT and pharma space. One can look for few IT stocks like Hexaware Technologies, Geometric at the...
Exit Opto Circuits: Sudarshan Sukhani
4.35 pm | 10 Jun 2013 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com advised exit out of Opto Circuits. It has been short since Rs 200.
Hold Sun Pharmaceuticals: Ventura
12.37 pm | 08 Jun 2013 | Source: Moneycontrol.com
Ventura has recommended hold rating on Sun Pharmaceuticals Industries, in its May 29, 2013 research report. The research firm expects, the company to ...
Cipla, Meda expand allergy drug collaboration
6.54 pm | 05 Jun 2013 | Source: Moneycontrol.com
Meda and Cipla will cooperate on allergic drug Dymista. Cipla will do the formulation and Meda will look after clinical development, marketing and sal...
Quick Links for Sun Pharmaceutical Industries
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.